Table of Contents
Basic Research
| Construction of adenoviral vector carrying Smad3D or Smad7 | |
| Jianjun QIN, Qinghua ZHOU, Yang QIN, Zhilin SUN, Feng ZHAO, Zefang SUN, Yanping WANG, Cheng YI, Wen ZHU | 169-171 |
| Effect of exogenous wild type p53 expression on sensitization of lung cancer cell line to cisplatin and cloning of the corresponding genes | |
| Hongtao ZHANG, Hui WANG, Baitang LAI, Chunyan ZHANG, Xuehui YANG | 172-175 |
| Angiogenesis and blood supply during the course of pulmonary carcinogenesis in experimental rat | |
| Xuan LIU, Honggang LI, Mingqiu LIU, Mingjun HAN, Chunling HU, Feng YU, Man JIANG, Fei YANG | 176-180 |
| Studies on proliferation inhibition and anti-invasion of retinoic acid and 18β-glycyrrhetinic acid in highly metastasized human lung cancer cell line | |
| Dongfang ZHANG, Wei HUANG, Jiqun HUANG, Zhaoquan LIAO | 181-184 |
Clinical Research
| Level of DNA adduct in lung cancer tissues and its influencing factors | |
| Zhi ZHANG, Xuemei ZHANG, Wenmin YANG, Zhanzhao FU | 185-187 |
| Tracheo-bronchoplasty and/or cardiovascular reconstruction in the treatment of centrally located lung cancer | |
| Jiaqi QU, Weiping HOU, Xin GAO, Hong TENG, Xiangdong TONG, Xiuyi YU | 188-190 |
| Preoperative hyperfractionated accelerated irradiation-induced apoptosis in non-small cell lung cancer | |
| Jun WANG, Daoan ZHOU, Aiqin XIAO, Chun HAN, Xin ZHANG, Guoxin MA | 191-194 |
| A prospective randomized trial comparing mitomycin C and vindesine and cisplatin versus pirarubicin and vindesine and cisplatin in the treatment of advanced non-small cell lung cancer | |
| Yanping YANG, Ding YU, Yuhua FAN, Yuhua KE, Xiaoyu FU, Yunhua ZHOU, Zhihua XIAO, Hui JIANG, Ling YANG | 195-197 |
| Value of FDG PET for mediastinal lymph node staging in non-small cell lung cancer | |
| Baixuan XU, Yanling LIU, Shulin YAO, Mingzhe SHAO, Yingmao CHEN, Kun WANG, Jiahe TIAN | 198-200 |
| Long-term results of chemotherapy alone or combined with radiation therapy for limited-stage small cell lung cancer | |
| Yulin HU, Yali CUI, Mingzhi WANG, Shouren CUI, Ruizhi WANG, Yongjun GAO, Yanfei YANG | 201-203 |
| The clinical analysis of lung cancer with paraneoplastic syndrome as initial symptom | |
| Ruijing WU, Wanqiang FANG, Li LIN | 204-205 |
| Diagnostic and prognostic values of serum CA125, NSE, CT levels in patients with lung cancer | |
| Zhanlin GUO, Lin QIU, Fengkun ZHANG, Fude YANG, Long ZHAO, Yulong ZHANG, Xianming ZHU, Nengyong QIU | 206-208 |
| A clinical study of ProGRP as a new tumor marker for small cell lung cancer | |
| Bingxiang YU, Qingfeng LIU, Liang'an CHEN | 209-210 |
| Efficacy comparison between hyperfractionated and conventional fractionated radiotherapy for non-small cell lung cancer | |
| Shengguang HE, Chunmei DENG, Ke XIE, Haitao LAN, Naiyao YE | 211-212 |
Rapid Communication
| CD44V6表达与肺鳞癌淋巴结转移的相关性分析 | |
| 邱 小芬, 李 德进, 蒋 旭 | 213-215 |
Clinical Experience
| 中医辨证综合治疗Ⅲ、Ⅳ期非小细胞肺癌生存质量及疗效的研究 | |
| 李 柳宁, 刘 伟胜, 徐 凯, 吴 万垠, 刘 宇龙, 朱 迪盈, 罗 海英, 陈 春永 | 216-219 |
| 肺原发性粘液表皮样癌的临床病理特点 | |
| 钟 定荣, 李 书敏, 王 湛博, 柳 曦 | 220-222 |
| TP、HP与NP方案治疗晚期NSCLC的近期疗效 | |
| 高 文斌, 尹 良伟, 王 怀瑾, 孙 玲, 戚 晓军, 张 雪梅, 董 华承, 李 鑫 | 223-225 |
| 电视辅助胸腔镜外科治疗原发性肺癌的初步观察 | |
| 伍 硕允, 叶 敏, 陈 志锦 | 226-227 |
| 吉西他滨联合异环磷酰胺及顺铂治疗中晚期非小细胞肺癌的临床研究 | |
| 吴 瑾, 乔 文波, 张 清媛 | 228-229 |
| 90例T1N2肺癌外科治疗结果分析 | |
| 白 连启, 龚 昌帆, 窦 学军, 刘 青春 | 230-231 |
| 诺维本加异环磷酰胺加顺铂联合治疗晚期非小细胞肺癌 | |
| 邵 湍, 陈 玉蓉, 赵 怡卓, 纪 灏, 廖 美琳 | 232-233 |
| 吉西他滨与顺铂治疗非小细胞肺癌的临床研究 | |
| 陈 明伟, 陈 健, 杜 风兰 | 234-235 |
Minireview
| 肺泡Ⅱ型上皮细胞及其分离鉴定与原代培养 | |
| 周 莉, 金 克炜 | 236-238 |
| N2非小细胞肺癌治疗进展 | |
| 毛 友生, 张 德超, 黄 国俊 | 239-241 |
| 外周血造血干细胞体外保存的研究进展 | |
| 彭 文珍, 周 宏远, 傅 继梁 | 242-244 |
| 树突状细胞疫苗的研究进展 | |
| 赵 峰, 周 清华 | 245-248 |
Short Communications
| 紫杉醇联合顺铂治疗晚期非小细胞肺癌43例临床疗效分析 | |
| 倪 秉洁 | 184 |
| 肺小结节手术诊治28例报告 | |
| 杜 开齐, 张 志豪, 张 锦贤, 施 谷平, 刘 万顺, 李 也梁, 胡 汛, 邬 冬强 | 215 |
Case Reports
| 肺腺癌前列腺转移一例报告 | |
| 谢 莉, 李 志平 | 222 |
| 肺鳞癌股二头肌间转移一例 | |
| 杨 祚璋, 谢 琳, 李 少莹, 许 建波, 李 琳, 杨 承刚 | 233 |
